(Q37826638)

23 August 2017

1 reference

title

The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment (English)

1 reference

23 August 2017

0 references

1 reference

cognitive dysfunction

1 reference

Herbert Y Meltzer

1

1 reference

23 August 2017

Masakuni Horiguchi

series ordinal

2

1 reference

23 August 2017

Bill W Massey

series ordinal

3

1 reference

23 August 2017

publication date

8 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

213

1 reference

23 August 2017

issue

2-3

1 reference

23 August 2017

page(s)

289-305

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-2137-8

23 August 2017

exact match

0 references

cites work

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

5HT antagonists attenuate MK801-impaired radial arm maze performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

[3H]WAYâ 100635 for 5â HT1A receptor autoradiography in human brain: a comparison with [3H]8â OHâ DPAT and demonstration of increased binding in the frontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Activation of 5-HT(6) receptors facilitates attentional set shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

An animal model of recognition memory and medial temporal lobe amnesia: history and current issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Role of 5-HT(2C) receptors in the control of central dopamine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Serotonin research: contributions to understanding psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Functional and anatomical aspects of prefrontal pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Identification of a serotonin/glutamate receptor complex implicated in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT7 receptor and disorders of the nervous system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Functional, molecular and pharmacological advances in 5-HT7 receptor research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Half a century of antipsychotics and still a central role for dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Phencyclidine-induced locomotor hyperactivity is enhanced in mice after stereotaxic brain serotonin depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The dopamine hypothesis of schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

5-HT(1A) receptors and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The role of 5-HT(1A) receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The 5-HT2C receptor antagonist RO 60-0491 counteracts rats' retention deficits in a recognition memory task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Dopamine D2 receptors as treatment targets in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Implications of animal object memory research for human amnesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-010-2137-8

21 January 2018

12 December 2020

[3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia

1 reference

12 December 2020

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

1 reference

12 December 2020

Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands

1 reference

12 December 2020

Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex

1 reference

12 December 2020

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

12 December 2020

Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists

1 reference

12 December 2020

The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)

1 reference

12 December 2020

Effects of the novel 5-HT1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats

1 reference

12 December 2020

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

12 December 2020

1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists

1 reference

12 December 2020

Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.

1 reference

12 December 2020

Involvement of dopamine D1 receptors in phencyclidine-induced behavioral stimulation in rats.

1 reference

12 December 2020

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2Asites for PCP-induced locomotion in the rat

1 reference

12 December 2020

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

1 reference

12 December 2020

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

12 December 2020

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs

1 reference

12 December 2020

Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.

1 reference

12 December 2020

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

1 reference

12 December 2020

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics

1 reference

12 December 2020

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile

1 reference

12 December 2020

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine a

1 reference

12 December 2020

Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.

1 reference

12 December 2020

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.

1 reference

12 December 2020

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.

1 reference

12 December 2020

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

1 reference

12 December 2020

Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors

1 reference

12 December 2020

Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.

1 reference

12 December 2020

The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives.

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats

1 reference

12 December 2020

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

12 December 2020

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1 reference

12 December 2020

Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin

1 reference

12 December 2020

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

1 reference

12 December 2020

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

1 reference

12 December 2020

10.1007/S00213-010-2137-8

Identifiers

DOI

1 reference

23 August 2017

1 reference